Differences in insulin secretion and sensitivity of Caucasian and African American prepubertal children

Gabriel I Uwaifo1, Tuc T Nguyen, Margaret F Keil

  • 1Unit on Growth and Obesity, Developmental Endocrinology Branch, National Institutes of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892-1862, USA.

Insights

African American children have reduced insulin sensitivity and higher insulin levels compared to Caucasian children, even after accounting for body composition differences. This suggests other factors influence metabolic health in youth.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Health
  • Body Composition Research

Background:

  • Differences in insulin sensitivity and secretion exist between racial groups in children.
  • Body composition is a key factor influencing metabolic health.
  • Understanding these differences is crucial for early identification and intervention.

Purpose of the Study:

  • To determine if body composition differences explain disparities in insulin sensitivity and secretion between African American (AA) and Caucasian (C) children.
  • To investigate racial differences in insulin dynamics and metabolic parameters in prepubertal children.

Main Methods:

  • A hyperglycemic clamp was used to assess insulin sensitivity (SI(clamp)) and secretion in 31 AA and 54 C prepubertal children.
  • Dual-energy X-ray absorptiometry (DXA) was employed to measure body composition.
  • Analysis included adjustments for body fat and lean mass.

Main Results:

  • AA children exhibited greater total body fat mass and higher fasting, first-phase, second-phase, and steady-state insulin levels compared to C children.
  • Despite similar glucose disposal rates, AA children had lower insulin sensitivity (SI(clamp)).
  • Lower C-peptide/insulin molar ratios in AA children suggest reduced hepatic insulin clearance.

Conclusions:

  • Prepubertal AA children demonstrate reduced insulin sensitivity and altered insulin/C-peptide secretion profiles compared to C children.
  • These metabolic differences are not fully explained by variations in adiposity.
  • Reduced hepatic insulin clearance may contribute to the observed metabolic disparities in AA children.
Abstract

Related Concept Videos

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...